drugset / Trial / NCT01626859
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the pharmacokinetics, safety and efficacy of MP-214 in patients with schizophrenia.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cariprazine | Small molecule | 3 mg | Oral |
| Subject | Cariprazine | Small molecule | 6 mg | Oral |
| Subject | Cariprazine | Small molecule | 9 mg | Oral |